- Home
- IMOS vs KURA Comparison
IMOS vs KURA Comparison
Compare IMOS & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMOS
- KURA
- Stock Information
- Founded
- IMOS 1997
- KURA 2014
- Country
- IMOS Taiwan
- KURA United States
- Employees
- IMOS N/A
- KURA N/A
- Industry
- IMOS Semiconductors
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IMOS Technology
- KURA Health Care
- Exchange
- IMOS Nasdaq
- KURA Nasdaq
- Market Cap
- IMOS 551.9M
- KURA 561.9M
- IPO Year
- IMOS N/A
- KURA N/A
- Fundamental
- Price
- IMOS $19.20
- KURA $5.80
- Analyst Decision
- IMOS
- KURA Strong Buy
- Analyst Count
- IMOS 0
- KURA 12
- Target Price
- IMOS N/A
- KURA $24.50
- AVG Volume (30 Days)
- IMOS 14.2K
- KURA 1.2M
- Earning Date
- IMOS 08-12-2025
- KURA 08-07-2025
- Dividend Yield
- IMOS 4.39%
- KURA N/A
- EPS Growth
- IMOS N/A
- KURA N/A
- EPS
- IMOS 0.05
- KURA N/A
- Revenue
- IMOS $685,506,006.00
- KURA $67,991,000.00
- Revenue This Year
- IMOS N/A
- KURA $109.86
- Revenue Next Year
- IMOS $2.21
- KURA $107.90
- P/E Ratio
- IMOS $19.57
- KURA N/A
- Revenue Growth
- IMOS 2.89
- KURA N/A
- 52 Week Low
- IMOS $12.78
- KURA $5.41
- 52 Week High
- IMOS $27.51
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- IMOS 53.27
- KURA 40.37
- Support Level
- IMOS $18.57
- KURA $5.73
- Resistance Level
- IMOS $19.78
- KURA $6.01
- Average True Range (ATR)
- IMOS 0.58
- KURA 0.31
- MACD
- IMOS -0.12
- KURA -0.08
- Stochastic Oscillator
- IMOS 31.19
- KURA 5.19
About IMOS ChipMOS TECHNOLOGIES INC.
ChipMOS TECHNOLOGIES Inc is engaged in the research, development, manufacturing, and sale of high-integration and high-precision integrated circuits and related assembly and testing services. The company's segments include Testing, Assembly, Testing, and Assembly for LCD, OLED, and other Display Panel Driver Semiconductors (LCDD), Bumping, and others. It derives a majority of its revenue from Taiwan followed by Japan, the People's Republic of China, Singapore, and others.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.